StreetInsider.com News Articles

Form 8-K Spectral AI, Inc. For: May 29

Mon, 01 Jun 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260601/26583342.html

Form 8-K Spectral AI, Inc. For: May 29

Mon, 01 Jun 2026 16:03:00 -0400

si-local-file:///var/storage/secattach/20260601/26583342.html

Form 4 Spectral AI, Inc. For: May 28 Filed by: DiMaio John Michael

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583291.html

Form 4 Spectral AI, Inc. For: May 28 Filed by: DiMaio John Michael

Mon, 01 Jun 2026 16:00:00 -0400

si-local-file:///var/storage/secattach/20260601/26583291.html

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Mon, 01 Jun 2026 08:00:00 -0400

Provides Update and Outlook Following Receipt of FDA De Novo Clearance for DeepView® System for Burn Indication

DALLAS, June 01, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced results from its 2026 Annual Meeting of Stockholders, held on May 29, 2026.

The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

Mon, 01 Jun 2026 08:00:00 -0400

Provides Update and Outlook Following Receipt of FDA De Novo Clearance for DeepView® System for Burn Indication

The Company also provided an overview of its accomplishments to date and targeted milestones for 2026 following the receipt of De Novo Classification for its DeepView® System from

Form 4 Spectral AI, Inc. For: May 26 Filed by: DiMaio John Michael

Wed, 27 May 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260527/26559133.html

Form 4 Spectral AI, Inc. For: May 26 Filed by: DiMaio John Michael

Wed, 27 May 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260527/26559133.html

Form 8-K Spectral AI, Inc. For: May 26

Tue, 26 May 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260526/26549678.html

Form 8-K Spectral AI, Inc. For: May 26

Tue, 26 May 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260526/26549678.html

Spectral AI (MDAI) PT Raised to $4 at BTIG

Tue, 26 May 2026 08:08:05 -0400

(Updated - May 26, 2026 8:08 AM EDT)

BTIG analyst Ryan Zimmerman raised the price target on Spectral AI (NASDAQ: MDAI) to $4.00 (from $3.00) while maintaining a Buy rating.

The analyst commented: "This morning, MDAI announced it received FDA clearance for the DeepView System for Burn Centers, Trauma Centers, and Emergency Departments. FDA clearance is a significant milestone for MDAI as the DeepView System has been in development and clinical investigation for numerous years. With clearance now secured, MDAI expects to begin its commercial launch in 2H26 and has previously noted that BARDA will support the distribution of ~30 systems into

Spectral AI (MDAI) PT Raised to $4 at BTIG

Tue, 26 May 2026 08:08:05 -0400

(Updated - May 26, 2026 8:08 AM EDT)

BTIG analyst Ryan Zimmerman raised the price target on Spectral AI (NASDAQ: MDAI) to $4.00 (from $3.00) while maintaining a Buy rating.

Spectral AI receives FDA clearance for burn wound assessment system

Tue, 26 May 2026 07:03:28 -0400

Spectral AI Inc. (NASDAQ: MDAI) announced the U.S. Food and Drug Administration granted De Novo Classification for its DeepView System, authorizing the company to begin commercial distribution in the United States. The device is intended for use in burn care across burn centers, trauma centers, and emergency departments.

The DeepView System combines multispectral imaging with artificial intelligence algorithms to assess burn wound healing potential. The device provides clinicians with data-driven assessments of whether areas within burn wounds are unlikely to heal within 21 days and may require medical intervention. Image acquisition takes 0.2 seconds, with processing and AI classification requiring approximately

Spectral AI receives FDA clearance for burn wound assessment system

Tue, 26 May 2026 07:03:28 -0400

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Tue, 26 May 2026 07:00:00 -0400

DALLAS, May 26, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that the U.S. Food and Drug Administration (FDA) granted De Novo Classification for its DeepView^® System. With this classification, Spectral AI is authorized to commence commercial distribution activities in the United States. The DeepView System is intended for use in burn care in various settings, including burn centers, trauma centers, and emergency departments.

“We are

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Tue, 26 May 2026 07:00:00 -0400

“We are

Form 4 Spectral AI, Inc. For: Apr 24 Filed by: Sadagopan Deepak

Wed, 20 May 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260520/26528085.html

Form 4 Spectral AI, Inc. For: Apr 24 Filed by: Sadagopan Deepak

Wed, 20 May 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260520/26528085.html

Form 4 Spectral AI, Inc. For: May 15 Filed by: Cotton Richard John

Mon, 18 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260518/26514492.html

Form 4 Spectral AI, Inc. For: May 15 Filed by: Cotton Richard John

Mon, 18 May 2026 16:34:00 -0400

si-local-file:///var/storage/secattach/20260518/26514492.html

Form 4 Spectral AI, Inc. For: May 15 Filed by: DiMaio John Michael

Mon, 18 May 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260518/26513557.html

Form 4 Spectral AI, Inc. For: May 15 Filed by: DiMaio John Michael

Mon, 18 May 2026 16:01:00 -0400

si-local-file:///var/storage/secattach/20260518/26513557.html

Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities

Wed, 13 May 2026 08:30:00 -0400

AUSTIN, Texas, May 13, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: For decades, reliably identifying drug and alcohol impairment has been a persistent problem across industries, from traffic enforcement and occupational safety to clinical medicine and public health. Conventional tools such as breathalyzers, blood draws and urine tests are hampered by their intrusiveness, slow turnaround times or inability to capture real-time impairment, especially when multiple substances are involved. As substance-use patterns shift and the broader societal costs of intoxication continue to mount, the pressure to develop faster, less invasive, and more scalable detection methods

Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities

Wed, 13 May 2026 08:30:00 -0400

Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities

Wed, 13 May 2026 08:30:00 -0400